FAETH THERAPEUTICS INC
FTHNASDAQ🏆 #2871 by market capUS Equity
$19.20▲ $0.06 (+0.31%)
Pre-market · at closeTrack FTH
Get earnings, price moves & breaking news on Telegram
24h▲ 0.3%
7d▼ 4.2%
14d▼ 6.5%
30d▼ 31.6%
ytd▲ 81.3%
1y▲ 104.0%
🏦Market Cap
$495M
Small Cap
📈Revenue Growth (YoY)
0.0%
Slowing
📊Gross Margin
2740.8%
High
💵FCF Margin
698.0%
Strong
⚖️P/S Ratio
-101.6x
Cheap
Otter Score
76
Strong
Trading Snapshot
- Day Range
- $19.18 – $20.30
- 52-Week Range
- $7.45 – $42.14
- Volume (shares)
- 12,633
- Avg Volume (shares)
- —
- Shares Outstanding
- 25.8M
- Next Earnings
- —
Fundamentals Snapshot
- Annual Revenue
- —
- Last Q Revenue
- —
- P/E Ratio
- -0.1
- P/S Ratio
- -101.6x
- EPS (TTM)
- $-34.65
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +0.3%
FAETH THERAPEUTICS INC
FTHFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0▲ +0.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$22M▼ −29.6% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$20M▼ −17.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
1.3M▲ +0.3% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$7M▲ +$1M YoY
StockOtter · stockotter.spaceAbout FAETH THERAPEUTICS INC
Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. [28, 70] The company's lead program, PIKTOR, is an investigational all-oral combination therapy targeting the PI3K/AKT/mTOR pathway. [28, 70]
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Strong
76/100
Analyst data unavailable.
Latest News & Updates
News unavailable.